Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different ovulation trigger regimens in normal responders undergoing antagonist IVF/ICSI cycles
ChiCTR2400079817Phase 4Not yet recruiting
- Sponsor
- Sichuan Academy of Medical Sciences& Sichuan Provincial People's Hospital
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of human chorionic gonadotropin and triptorelin in infertility (3 arms), sponsored by Sichuan Academy of Medical Sciences& Sichuan Provincial People's Hospital. Primary endpoints: MII oocyte rate, Number of 2PN embryos and 11 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
human chorionic gonadotropintriptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2400079817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079817.